Form 8-K Mereo BioPharma Group For: Mar 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- BuzzFeed cuts 35% of workforce in restructuring move
Mereo BioPharma director Jenkins won't seek re-election at 2026 meeting
March 27, 2026 6:16 AM EDTMereo BioPharma Group (NASDAQ: MREO) announced that Dr. Annalisa Jenkins will not stand for re-election as a director at the company's 2026 annual general meeting scheduled for May 14, 2026.
Jenkins informed the pharmaceutical company of her decision on March 26, 2026. She will continue serving... More
